A citation-based method for searching scientific literature

Kristi D Graves, Kara-Grace Leventhal, Rachel Nusbaum, Yasmin Salehizadeh, Gillian W Hooker, Beth N Peshkin, Morgan Butrick, William Tuong, Jeena Mathew, David Goerlitz, Mary B Fishman, Peter G Shields, Marc D Schwartz. Genomics 2013
Times Cited: 26







List of co-cited articles
134 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.
Rachel Nusbaum, Kara-Grace Leventhal, Gillian W Hooker, Beth N Peshkin, Morgan Butrick, Yasmin Salehizadeh, William Tuong, Susan Eggly, Jeena Mathew, David Goerlitz,[...]. Transl Behav Med 2013
19
36

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
177
26

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
281
26

A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Amelia K Smit, David Espinoza, Ainsley J Newson, Rachael L Morton, Georgina Fenton, Lucinda Freeman, Kate Dunlop, Phyllis N Butow, Matthew H Law, Michael G Kimlin,[...]. Cancer Epidemiol Biomarkers Prev 2017
33
23

Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.
Amelia K Smit, Louise A Keogh, Ainsley J Newson, Jolyn Hersch, Phyllis Butow, Anne E Cust. Public Health Genomics 2015
13
38

Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial.
Richard W Grant, Kelsey E O'Brien, Jessica L Waxler, Jason L Vassy, Linda M Delahanty, Laurie G Bissett, Robert C Green, Katherine G Stember, Candace Guiducci, Elyse R Park,[...]. Diabetes Care 2013
96
15

"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer.
Kara-Grace Leventhal, William Tuong, Beth N Peshkin, Yasmin Salehizadeh, Mary B Fishman, Susan Eggly, Kevin FitzGerald, Marc D Schwartz, Kristi D Graves. J Genet Couns 2013
27
15




Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
15

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
69
15

"It's not like judgment day": public understanding of and reactions to personalized genomic risk information.
Erynn S Gordon, Georgia Griffin, Lisa Wawak, Hauchie Pang, Sarah E Gollust, Barbara A Bernhardt. J Genet Couns 2012
48
15

Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Mary-Anne Young, Laura Elenor Forrest, Victoria-Mae Rasmussen, Paul James, Gillian Mitchell, Sarah Dilys Sawyer, Katrina Reeve, Nina Hallowell. J Genet Couns 2018
21
19

The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.
Elizabeth K Bancroft, Elena Castro, Gordon A Bancroft, Audrey Ardern-Jones, Clare Moynihan, Elizabeth Page, Natalie Taylor, Rosalind A Eeles, Emma Rowley, Karen Cox. Psychooncology 2015
18
22

Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Ellen R Gritz, Susan K Peterson, Sally W Vernon, Salma K Marani, Walter F Baile, Beatty G Watts, Christopher I Amos, Marsha L Frazier, Patrick M Lynch. J Clin Oncol 2005
90
11

Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
Donald W Hadley, Jean F Jenkins, Eileen Dimond, Maria de Carvalho, Ilan Kirsch, Christina G S Palmer. J Clin Oncol 2004
113
11

Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.
K D Graves, B N Peshkin, G Luta, W Tuong, M D Schwartz. Public Health Genomics 2011
45
11

Reduced melanoma after regular sunscreen use: randomized trial follow-up.
Adèle C Green, Gail M Williams, Valerie Logan, Geoffrey M Strutton. J Clin Oncol 2011
412
11

Reducing death from melanoma and standards of evidence.
Martin A Weinstock. J Invest Dermatol 2012
13
23

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010
203
11

Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
94
11

Health behavior change: can genomics improve behavioral adherence?
Colleen M McBride, Angela D Bryan, Molly S Bray, Gary E Swan, Eric D Green. Am J Public Health 2012
42
11

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
68
11

Public preferences for communicating personal genomic risk information: a focus group study.
Amelia K Smit, Louise A Keogh, Jolyn Hersch, Ainsley J Newson, Phyllis Butow, Gabrielle Williams, Anne E Cust. Health Expect 2016
26
11

Psychological impact of genetic testing in women from high-risk breast cancer families.
B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
93
11

A role for common genomic variants in the assessment of familial breast cancer.
Sarah Sawyer, Gillian Mitchell, Joanne McKinley, Georgia Chenevix-Trench, Jonathan Beesley, Xiao Qing Chen, David Bowtell, Alison H Trainer, Marion Harris, Geoffrey J Lindeman,[...]. J Clin Oncol 2012
60
11

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
Serena Chao, J Scott Roberts, Theresa M Marteau, Rebecca Silliman, L Adrienne Cupples, Robert C Green. Alzheimer Dis Assoc Disord 2008
166
11

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
71
11

"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer.
Elizabeth K Bancroft, Elena Castro, Audrey Ardern-Jones, Clare Moynihan, Elizabeth Page, Natalie Taylor, Rosalind A Eeles, Emma Rowley, Karen Cox. Fam Cancer 2014
13
23

Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
A K Smit, L A Keogh, A J Newson, P N Butow, K Dunlop, R L Morton, J Kirk, D Espinoza, A E Cust. Br J Dermatol 2017
13
23


Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial.
David S Weinberg, Ronald E Myers, Eileen Keenan, Karen Ruth, Randa Sifri, Barry Ziring, Eric Ross, Sharon L Manne. Ann Intern Med 2014
29
11

Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis.
Kelly F J Stewart, Anke Wesselius, Maartje A C Schreurs, Annemie M W J Schols, Maurice P Zeegers. J Community Genet 2018
42
11

Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening.
Mark A Jenkins, Enes Makalic, James G Dowty, Daniel F Schmidt, Gillian S Dite, Robert J MacInnis, Driss Ait Ouakrim, Mark Clendenning, Louisa B Flander, Oliver K Stanesby,[...]. Future Oncol 2016
28
11

Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review.
Tatiane Yanes, Amanda M Willis, Bettina Meiser, Katherine M Tucker, Megan Best. Eur J Hum Genet 2019
32
11

Clinical use of current polygenic risk scores may exacerbate health disparities.
Alicia R Martin, Masahiro Kanai, Yoichiro Kamatani, Yukinori Okada, Benjamin M Neale, Mark J Daly. Nat Genet 2019
734
11

Assessment of clinical practices among cancer genetic counselors.
Deborah Wham, Thuy Vu, Gayun Chan-Smutko, Christine Kobelka, Diana Urbauer, Brandie Heald. Fam Cancer 2010
43
7

How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.
Stephanie Sivell, Glyn Elwyn, Clara L Gaff, Angus J Clarke, Rachel Iredale, Chris Shaw, Joanna Dundon, Hazel Thornton, Adrian Edwards. J Genet Couns 2008
93
7

Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment.
Noriko Ishii, Masami Arai, Yurie Koyama, Masashi Ueno, Toshiharu Yamaguchi, Keiko Kazuma, Tetsuichiro Muto. Fam Cancer 2011
15
13

Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.
Erna Claes, Lieve Denayer, Gerry Evers-Kiebooms, Andrea Boogaerts, Eric Legius. Patient Educ Couns 2004
63
7

Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations.
Katarina Bartuma, Mef Nilbert, Christina Carlsson. Hered Cancer Clin Pract 2012
14
14

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
943
7

Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale.
Catherine Y Read, Donna J Perry, Mary E Duffy. J Nurs Scholarsh 2005
42
7

Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels.
Katarina Domanska, Christina Carlsson, Pär-Ola Bendahl, Mef Nilbert. BMC Med Genet 2009
23
8

Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Veronica Collins, Bettina Meiser, Clara Gaff, D James B St John, Jane Halliday. Cancer 2005
58
7

Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer.
S W Vernon, E R Gritz, S K Peterson, C I Amos, C A Perz, W F Baile, P M Lynch. Health Psychol 1997
83
7

Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients.
Kira A Apse, Barbara B Biesecker, Francis M Giardiello, Barbara P Fuller, Barbara A Bernhardt. Genet Med 2004
42
7

Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study.
Scott Ramsey, David Blough, Cara McDermott, Lauren Clarke, Robin Bennett, Wylie Burke, Polly Newcomb. Public Health Genomics 2010
17
11

Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.
P T Campbell, K Curtin, C M Ulrich, W S Samowitz, J Bigler, C M Velicer, B Caan, J D Potter, M L Slattery. Gut 2009
85
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.